According to filings with the U.S. Securities and Exchange Commission, Biosim is raising up to $12,250,000.00 in new funding. Sources indicate that as part of senior management President, Garegin Papoian played a key role in securing the recent investment and it will aid in aggressively expanding the company, as well as broaden and accelerate product development.

About Biosim
BiosimAI has joined forces with Deep Origin. The combined company is accelerating drug discovery by combining cutting-edge quantum chemistry, biophysics simulation, AI, and scientific computing. We aim to reduce small-molecule drug discovery from years to months. Our world-class team is led by our founders Michael Antonov and Garegin Papoian. To join our team, please see our job openings.

To learn more about Biosim, visit http://www.deeporigin.com/

Contact:
Garegin Papoian, President
781-862-4371
https://www.linkedin.com/in/garegin-papoian-9472a85/

SOURCE: http://www.intelligence360.io
Copyright (c) 2024 SI360 Inc. All rights reserved.